Fibroblast-derived CXCL12 increases vascular permeability in a 3-D microfluidic model independent of extracellular matrix contractility.

MLA

Holter, Jacob C., et al. “Fibroblast-Derived CXCL12 Increases Vascular Permeability in a 3-D Microfluidic Model Independent of Extracellular Matrix Contractility.” Frontiers in Bioengineering and Biotechnology, vol. 10, Sept. 2022, p. 888431. EBSCOhost, https://doi.org/10.3389/fbioe.2022.888431.

APA

Holter, J. C., Chang, C.-W., Avendano, A., Garg, A. A., Verma, A. K., Charan, M., Ahirwar, D. K., Ganju, R. K., & Song, J. W. (2022). Fibroblast-derived CXCL12 increases vascular permeability in a 3-D microfluidic model independent of extracellular matrix contractility. Frontiers in Bioengineering and Biotechnology, 10, 888431. https://doi.org/10.3389/fbioe.2022.888431

Chicago

Holter, Jacob C, Chia-Wen Chang, Alex Avendano, Ayush A Garg, Ajeet K Verma, Manish Charan, Dinesh K Ahirwar, Ramesh K Ganju, and Jonathan W Song. 2022. “Fibroblast-Derived CXCL12 Increases Vascular Permeability in a 3-D Microfluidic Model Independent of Extracellular Matrix Contractility.” Frontiers in Bioengineering and Biotechnology 10 (September): 888431. doi:10.3389/fbioe.2022.888431.